Luca Santarelli is the founder of VectivBio. VectivBio has raised $35M in total funding. Latest round: IPO. Based in Risch, Switzerland.
Luca Santarelli is the CEO of VectivBio, a company focused on rare diseases. Founded three years ago by the Roche veteran, VectivBio went public a year ago and recently secured over $100 million in new funding through a licensing pact and a loan. The company aims to advance its pipeline in rare disease treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library